Medical imaging device developer Cognoptix has named its president and CEO, Paul D. Hartung, chairman of the company’s board of directors. In addition, Dr. Christine de los Reyes, vice president of business development and strategic planning for Alopexx Enterprises, has also joined the board. Hartung serves on the board of directors of the Medical Development Group and has extensive experience in the laser and medical device industries. De los Reyes is founder and managing director of BiotechPartnering Solutions and a member of the advisory board of the Neurotechnology Industry Organization. Cognoptix is a medical imaging device company developing the Sapphire II eye test, which is designed to identify patients with Alzheimer’s disease via a beta-amyloid plaque signature in their eyes. For more information, visit www.cognoptix.com.